Arctic Bioscience AS (OSL:ABS)
Norway · Delayed Price · Currency is NOK 3.000
-0.240 (-7.41%)
Jul 15, 2026, 4:27 PM CET
Arctic Bioscience AS Market Cap
Arctic Bioscience AS has a market cap or net worth of 80.87 million as of July 15, 2026. Its market cap has decreased by -11.19% in one year.
Market Cap
80.87M
Enterprise Value
141.90M
Revenue
42.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.00
Market Cap Chart
Since February 24, 2021, Arctic Bioscience AS's market cap has decreased from 668.24M to 80.87M, a decrease of -87.90%. That is a compound annual growth rate of -32.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 80.87M | -8.54% |
| Dec 30, 2025 | 88.42M | 90.44% |
| Dec 30, 2024 | 46.43M | -82.57% |
| Dec 29, 2023 | 266.38M | -7.39% |
| Dec 30, 2022 | 287.63M | -33.50% |
| Dec 30, 2021 | 432.53M | -35.27% |
| Feb 24, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 1.79B |
| Thor Medical ASA | 1.54B |
| ArcticZymes Technologies ASA | 967.80M |
| Nykode Therapeutics AS | 917.60M |
| Lytix Biopharma ASA | 710.56M |
| Zelluna ASA | 647.10M |
| Oncoinvent ASA | 358.27M |
| SoftOx Solutions AS | 235.20M |